Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijcha.2020.100637 http://scihub22266oqcxt.onion/10.1016/j.ijcha.2020.100637 32953967!7486053!32953967     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32953967&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Int+J+Cardiol+Heart+Vasc 2020 ; 30 (?): 100637 Nephropedia Template TP {{tp|p=32953967|t=2020. COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients |pdf=|usr=}}{{32953967}} gab.com Text COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients JO: Int J Cardiol Heart Vasc http://www.kidney.de/pget.php?&tw=1&pmid=32953967 #FOAvip BACKGROUND: SARS-CoV-2 infection has caused a global pandemic. Many of the medications identified to treat COVID-19 could be connected with QTc prolongation and its consequences. METHODS: Non-ICU hospitalized patients of the three centres involved in the study from the 19th of March to the 1st of May were included in this retrospective multicentre study. Relevant clinical data were digitally collected. The primary outcome was the incidence of QTc prolongation >/= 500 ms, the main secondary outcomes were the Tisdale score ability to predict QTc prolongation and the incidence of ventricular arrhythmias and sudden deaths. RESULTS: 196 patients were analysed. 20 patients (10.2%) reached a QTc >/= 500 ms. Patients with QTc >/= 500 ms were significantly older (66.7 +/- 14.65 vs 76.6 +/- 8.77 years p: 0.004), with higher Tisdale score (low 56 (31.8%) vs 0; intermediate 95 (54.0%) vs 14 (70.0%); high 25 (14.2%) vs 6 (30.0%); p: 0.007) and with higher prognostic lab values (d-dimer 1819 +/- 2815 vs 11486 +/- 38554 ng/ml p: 0.010; BNP 212.5 +/- 288.4 vs 951.3 +/- 816.7 pg/ml p < 0.001; procalcitonin 0.27 +/- 0.74 vs 1.33 +/- 4.04 ng/ml p: 0.003). After a multivariate analysis the Tisdale score was able to predict a QTc prolongation >/= 500 ms (OR 1,358 95% CI 1,076-1,714p: 0,010). 27 patients died because of COVID-19 (13.7%), none experienced ventricular arrhythmias, and 2 (1.02%) patients with concomitant cardiovascular condition died of sudden death. CONCLUSIONS: In our population, a QTc prolongation >/= 500 ms was observed in a minority of patients, no suspected fatal arrhythmias have been observed. Tisdale score can help in predicting QTc prolongation. Twit Text FOAVip COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients ????Int J Cardiol Heart Vasc http://www.kidney.de/pget.php?&tw=1&pmid=32953967 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32953967 #FOAvip English Wikipedia <ref>{{Cite pmid|32953967}}</ref> COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients #MMPMID32953967 Bianco M; Biole CA; Campagnuolo S; Pietrangiolillo F; Spirito A; Galluzzo A; Nunez-Gil I; Destefanis P; Luciano A; Carvalho P; Varalda GP; Previti A; Gravellone M; Travieso Gonzalez A; Ugo F; Pivano G; Rametta F; Perboni A; Pozzi R; Montagna L; Cerrato E Int J Cardiol Heart Vasc 2020[Oct]; 30 (?): 100637 PMID32953967show ga BACKGROUND: SARS-CoV-2 infection has caused a global pandemic. Many of the medications identified to treat COVID-19 could be connected with QTc prolongation and its consequences. METHODS: Non-ICU hospitalized patients of the three centres involved in the study from the 19th of March to the 1st of May were included in this retrospective multicentre study. Relevant clinical data were digitally collected. The primary outcome was the incidence of QTc prolongation >/= 500 ms, the main secondary outcomes were the Tisdale score ability to predict QTc prolongation and the incidence of ventricular arrhythmias and sudden deaths. RESULTS: 196 patients were analysed. 20 patients (10.2%) reached a QTc >/= 500 ms. Patients with QTc >/= 500 ms were significantly older (66.7 +/- 14.65 vs 76.6 +/- 8.77 years p: 0.004), with higher Tisdale score (low 56 (31.8%) vs 0; intermediate 95 (54.0%) vs 14 (70.0%); high 25 (14.2%) vs 6 (30.0%); p: 0.007) and with higher prognostic lab values (d-dimer 1819 +/- 2815 vs 11486 +/- 38554 ng/ml p: 0.010; BNP 212.5 +/- 288.4 vs 951.3 +/- 816.7 pg/ml p < 0.001; procalcitonin 0.27 +/- 0.74 vs 1.33 +/- 4.04 ng/ml p: 0.003). After a multivariate analysis the Tisdale score was able to predict a QTc prolongation >/= 500 ms (OR 1,358 95% CI 1,076-1,714p: 0,010). 27 patients died because of COVID-19 (13.7%), none experienced ventricular arrhythmias, and 2 (1.02%) patients with concomitant cardiovascular condition died of sudden death. CONCLUSIONS: In our population, a QTc prolongation >/= 500 ms was observed in a minority of patients, no suspected fatal arrhythmias have been observed. Tisdale score can help in predicting QTc prolongation. ?COVID-19 therapies and their impact on QT interval prolongation: A mul(epmc).pdf DeepDyve Pubget Overpricing